2021 HIDA Influenza Vaccine Production And Distribution Market Report
The 2020-2021 flu season saw the lowest rate of flu related hospitalizations since 2005. Social distancing, remote schooling and work from home policies due to the COVID-19 pandemic all contributed to the decline. As schools and offices reopen before the 2021-2022 flu season, cases, hospitalizations and deaths are expected to rise. The 2021 HIDA Influenza Vaccine Production & Distribution Market Report provides insights into the upcoming flu season including: the impact of COVID-19, vaccine makeup, vaccine effectiveness, and reimbursement. Insights include:
There were 2,038 flu cases in 2020-2021, down from 38 million the previous year.
- The U.S. influenza vaccine market is expected to surpass $8.6 billion by 2027.
- 50-55% of adults received a flu vaccine in 2020-2021, up from 48% the prior year.
Purchase a PDF license for your entire team allowing unlimited distribution within your company.
Single download for members: Free | Non-members: $50
License price for members: $1550 | Non-members: $1550